Sentences with phrase «pharmaceutical compounds on»

So does the testing of biomedical or pharmaceutical compounds on primates really advance medicine?
No one expects their doctor to repair to the lab every night to prepare pharmaceutical compounds on the theory that she alone knows what her patients need.
Toxicity assessment of pharmaceutical compounds on mixed culture from activated sludge using respirometric technique: The role of microbial community structure — I.A. Vasiliadou, Science of The Total Environment

Not exact matches

Founded in 2010, Vet's First Choice provides FDA - and EPA - approved pharmaceuticals, therapeutic diets, and compounded medications to pet owners on behalf of veterinary practices.
Two years ago the pharmaceutical giant GlaxoSmithKline purchased Sirtris for $ 720 million, and by August of last year The New York Times was speculating that compounds capable of activating sirtuin genes were now the leading candidates for what the newspaper called «the ultimate free lunch... a drug that tricks the body into thinking it is on [a calorie - restricted] diet.»
They focused on reactions that create alkoxysilanes — a common ingredient in ceramics and in organic compounds used in agriculture and pharmaceuticals.
Eng's 1996 conference presentation on a compound in Gila monster venom that affects insulin production caught the attention of biotechnology company Amylin Pharmaceuticals.
Now Abbott Laboratories, Bristol - Myers Squibb, GlaxoSmithKline, Sanofi, and Janssen Pharmaceuticals have signed on, bringing the number of compounds to 58.
Rather than remaining unused on the shelf of a pharmaceutical company or academic laboratory, drug compounds become available for other uses.
These risks and uncertainties include, among others, those relating to our ability to obtain financing and to form collaborative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
Instead of using a set of genes to induce the cellular transformation, he relies primarily on pharmaceutical compounds, known as «small molecules.»
These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
A collaboration with the Roche pharmaceutical company led to the screening of 200 000 Roche compounds on human neural stem cells in order to identify proliferative drugs.
These risks and uncertainties include, among others, those relating to our ability to obtain sufficient financing to continue as a going concern, the outcome of the review of the continued listing of our common stock on The Nasdaq Stock Market, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, our ability to form collaborative relationships, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10 - Q or Current Reports on Form 8 - K.
In ensuing experiments, Dr. Ding hopes to rely only on microRNAs and pharmaceutical compounds to convert skin cells to brain cells, which should lead to more efficient generation of cells for testing and regenerative purposes.
Anti-doping rules cloud the issues of what is «natural» and what isn't, pharmaceutical - type labeling on herbal remedies and wild claims regarding performance enhancement or fat loss (rightly) turn most consumers into skeptics, and massive price tags on tubs of sugar with trace amounts of «popular» compounds give a warped sense of the cost of high performance.
But what most people may not know, is that some of the most powerful pharmaceutical drugs on the market, are made from plant extracts or based on natural, nutritional compounds.
For one thing, DCA is extremely cheap, and for another, because no pharmaceutical company in existence has a patent on the DCA compound, they can not claim it as their own and profit from it.
Since it is not available commercially, a specialty pharmacy can therefore compound methimazole into a topical gel or liquid to be applied on the skin of the cat to achieve the desired pharmaceutical action.
If a client has a novel compound that is useful as an active pharmaceutical ingredient or even as an intermediate, then we try to obtain a patent on that compound for our client.
Pharmacy Technicians deals with many responsibilities and duties such as count tables, compound, pack and label pharmaceutical products, choose the correct prescription container and level it, work on joint project with pharmacy technicians of other pharmacy companies, and calculate the price of the prescription.
Accurately recorded compounded products and prepared appropriate labels.Retrieved, counted and measured drugs and capped and uncapped vials and bottles.Labeled all products appropriately, including cautionary and auxiliary labels.Processed up to 100 prescriptions on high volume days with 100 % accuracy.Mixed various pharmaceutical preparations according to written prescriptions.Calculated, weighed, measured and mixed ingredients with expert precision.Consistently upheld proper pharmacy and general safety procedures and standards.Consistently upheld proper pharmacy and general safety procedures and standards.
a b c d e f g h i j k l m n o p q r s t u v w x y z